8Esnaola NF,Lauwers GY,Mirza NQ,et al.Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation[J].J Gastrointest Surg,2002,6 (2):224-232.
9Veltri A,Grosso M,Martina MC,et al.Effect of preoperative radiological treatment of hepatocellular carcinoma before liver transplantation:a retrospective study[J].Cardiovasc Intervnt Radiol,1998,21 (5):393 -398.
1Shu-Sen Zheng, Zhi-Yong Yu, Ting-Bo Liang, Wei-Lin Wang, Yan Shen, Min Zhang, Xiao Xu and Jian Wu Hangzhou, China Centre of Organ Transplantation and Department o Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital of Medica College, Zhcjiang University, Hangzhou 310003, China.Prevention and treatment of hepatic artery thrombosis after liver transplantation[J].Hepatobiliary & Pancreatic Diseases International,2004,3(1):21-25. 被引量：18
2Jing-Hang Xu, Yan-Yan Yu, Chong-Wen Si, Zheng Zeng, Qin-Huan Wang, Duan-De Luo,Yong-Xing Zhou, Min-De Zeng, Guang-Yan Qiao, Ji-Lu Yao and Wei-Lun Lu Department of Infectious Diseases, First Hospital ofBeijing University, Beijing 100034, China ,Department of Gastroenterology, Wuhan UnionHospital, Wuhan 430022, China ,Department of Gastroentero-logy , Affiliated Tangdu Hospital, Fourth Military Medical University, Xi’an 710038, China ,Department of Gastroenterology, RenjiHospital, Shanghai 200001 , China ,Department of InfectiousDiseases, Second Affiliated Hospital, China Medical University, Shenyang110004, China ,Department of Gastroenterology, Third Affilia-ted Hospital, China Medical University, Shenyang 110004 , China.Promoting hepatic growth factor in the treatment of heavy type hepatitis and severe chronic hepatitis: a multicenter clinical study[J].Hepatobiliary & Pancreatic Diseases International,2004,3(3):381-385. 被引量：7
6Fox IJ, Chowdhury JR, Kaufman SS, et al. Treatment of the Crigler-Najjar syndrome type Ⅰ with hepatocyte transplantation. N Engl J Med,1998,338: 1422-1426.
7Fox IJ, Chowdhury JR, Kaufman SS, et al. Treatment of the CriglerNajjar syndrome type I with hepatocyte transplantation. N Engl J Med,1998,338:1422-1426.
8Mccauley J, Van Thiel DH, Starzl TE, et al. Acute and chronic renal failure in liver transplantation. Nephron,1990, 55: 121-128.
9Bilbao I, Charco R, Balsells JL, et al. Risk factors for acute renal failure requiring dialysis after liver transplantation . Clin Transplant, 1998, 12: 123-129.
10Lafayette RA, Pare G, Schmid CH, et al. Pretransplant renal dysfunction predicts poorer outcome in liver transplantation. Clin Nephrol, 1997, 48: 159-164.
2Zaak D,Paquet KJ,Kuhn R. Prospective study comparing human albumin vs reinfusion of uhrafiltrate-ascitic fluid after total paracentesis in cirrhotic patients with tense ascites[ J]. Z Gastroenterol,2001, 39(1) :5-10.
3Mehta NN, Alraham P, Ashar V J, et al. Ascitie fluid filtration and intravenous infusion versus total-v-lume paraeentesis with infusion of plasma expander in cirrhosis with tense or intractable ascites[ J]. Indian J Gastroenterol, 1998,17 ( 3 ) : 80-82.
4Antillon MR, Runyon BA. Extracorporeal uhrafiltration and intraveneous reinfusion of ascitic fluid vs large-volume paracentesis: a randomized controlled trial[ J]. Hepatology, 1993,17 ( 3 ) :520-522.
5Finfer S, Bellomo R, Myburgh J. Efficacy of albumin in critically ill patients: large trial in Australia and New Zealand may provide an answer[ J ]. BMJ ,2003,326 ( 3 ) :559-560.
